Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia-Reference-Cited by-同舟云学术

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia

Published:2021-12-09 Issue:1 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Fisher‐Wellman Kelsey H.¹,Hagen James T.¹,Kassai Miki²,Kao Li‐Pin²,Nelson Margaret A. M.¹,McLaughlin Kelsey L.¹,Coalson Hannah S.¹,Fox Todd E.³,Tan Su‐Fern⁴,Feith David J.⁴⁵,Kester Mark⁴⁵,Loughran Thomas P.⁴⁵,Claxton David F.⁶⁷,Cabot Myles C.²

Affiliation:

1. Department of Physiology, Brody School of Medicine, and the East Carolina Diabetes and Obesity Institute East Carolina University Greenville North Carolina USA

2. Department of Biochemistry & Molecular Biology, Brody School of Medicine, and the East Carolina Diabetes and Obesity Institute East Carolina University Greenville North Carolina USA

3. Department of Pharmacology University of Virginia School of Medicine Charlottesville Virginia USA

4. Department of Medicine, Hematology/Oncology University of Virginia School of Medicine Charlottesville Virginia USA

5. University of Virginia Cancer Center Charlottesville Virginia USA

6. Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine Hershey Pennsylvania USA

7. Penn state Cancer Institute Hershey Pennsylvania USA

Funder

U.S. Department of Defense

National Cancer Institute

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology